Table 1.
Compounda | [M + H]+ | MS/MS Fragments, m/zb | MS3 Fragment, m/z |
---|---|---|---|
Dopamine | 314 | 137, 178, 190, 259 | |
4-hydroxy-3-methoxybenzylamine | 137, 178 | ||
Norepinephrine | 330 | 161, 188, 312 | 152c |
5-hydroxydopamine | 153, 178, 206, 275 | ||
6-hydroxydopamine | 151, 153, 178, 275 | ||
Epinephrine | 344 | 137, 166, 190, 208 | |
dl-normetanephrine | 175, 202, 326 | ||
GABA | 264 | 161, 178, 191, 209 | 191d |
dl-2-aminobutyric acid | 161, 218 | ||
2-aminoisobutyric acid | 161,218 | ||
dl-3-aminoisobutyric acid | 161, 190, 209, 246 | 153d | |
N-ethylglycine | 151, 161, 181 | ||
N-methyl-L-alanine | 128, 137, 161 | ||
Tryptophan | 365 | 178, 236, 272, 348 | |
Tyrosine | 342 | 161, 165, 342182, 296 | |
Glutamic acid | 308 | 148, 161, 262, 290 | |
Serotonin | 337 | 160, 178, 228, 282, 294, 308, 320 | |
Melatonin | 393 | 233, 243, 269, 334 |
Derivatized (with 4-hydroxy-3-methoxycinnamaldehyde) amino acid or neurotransmitter is underlined with its isobaric analog listed below
Target amino acid or neurotransmitter fragment mass highlighted in bold if used for ion image reconstruction
Transition used for norepinephrine-CA (m/z 330→312→152) ion image reconstruction
Fragment mass used for confirmation of identity (m/z 264→209→)